Haemonetics Enters Oversold Territory
- On 2:02 pm EDT, Monday October 19, 2009
Haemonetics Corp.’s (NYSE: HAE - News) share price has entered into oversold territory with a stochastic value of 19.55. Analysts have been increasing their estimates on the company’s full-year earnings, sending the Zacks Consensus Estimate up a penny over the past 2 months to $2.81 per share. Haemonetics is a Zacks #2 Rank (“Buy) company.
HAEMONETICS CORP (HAE): Free Stock Analysis Report
|
Related Headlines
- Trading Review for Cerus Corp. Issued by Beacon Equity - GlobeNewswire
- Coverage initiated on Haemonetics by Morgan Keegan - Briefing.com
- HAEMONETICS CORP Financials - EDGAR Online Financials
- HAEMONETICS CORP Files SEC form 10-Q, Quarterly Report - EDGAR Online
- Plasma revenue lifts Haemonetics fiscal 2Q profit - AP
Related Blog Headlines
- Advocate Renews Deal with Masimo - Zacks.com
- CFN Enters Agreement with Masimo - Zacks.com
- Masimo Beats Zacks Estimate - Zacks.com
- Haemonetics Reports Strong Results - Zacks.com
- Haemonetics Enters Oversold Territory - Zacks.com
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale.
-
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today. -
Super Cheap Car Insurance
Get Discount Car Insurance Quotes Online – Rates from $15 / Month.
Add Alert © 2009 Zacks.com. All rights reserved.